Bicycle Therapeutics is a biotechnology company focused on developing precision-guided therapeutics to target intractable cancers and other serious diseases. Their mission is to create innovative medicines that have a transformative impact on patient lives by penetrating deep into tissues to address hard-to-target areas. While the company's primary focus is on solid tumor cancers, their technology also holds promise for a variety of therapeutic applications beyond oncology, such as anti-infective and cardiovascular treatments. Bicycle Therapeutics collaborates with pharmaceutical partners and academic leaders to explore new applications of their unique technology.
Drug Discovery β’ Phage Display β’ Peptide Therapeutics β’ Biotechnology
201 - 500 employees
Founded 2015
𧬠Biotechnology
π Pharmaceuticals
π¬ Science
π° $175M Post-IPO Equity on 2021-10
November 10
Direct global isotope supply chain for Bicycle Therapeutics' innovative medicines.
πΊπΈ United States β Remote
π Massachusetts β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π Senior
π Director
π¦ H1B Visa Sponsor
November 10
Lead compliance and ethics for Bicycle Therapeutics, a biopharmaceutical company.
πΊπΈ United States β Remote
π Massachusetts β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π΄ Lead
π Compliance
π¦ H1B Visa Sponsor